metformin has been researched along with Dunnigan Syndrome in 5 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Pioglitazone was added to her treatment, and follow-up showed improvement of metabolic control 7 months after introducing pioglitazone, and improvement of insulin sensitivity 2 years later." | 7.75 | Long-term improvement of metabolic control with pioglitazone in a woman with diabetes mellitus related to Dunnigan syndrome: a case report. ( Beressi, JP; Billon-Bancel, A; Collet-Gaudillat, C, 2009) |
| " Pioglitazone was added to her treatment, and follow-up showed improvement of metabolic control 7 months after introducing pioglitazone, and improvement of insulin sensitivity 2 years later." | 3.75 | Long-term improvement of metabolic control with pioglitazone in a woman with diabetes mellitus related to Dunnigan syndrome: a case report. ( Beressi, JP; Billon-Bancel, A; Collet-Gaudillat, C, 2009) |
| "Treatment with metformin resulted in progressive improvement of metabolic status, while blood pressure values normalized with atenolol therapy." | 1.40 | LMNA gene mutation as a model of cardiometabolic dysfunction: from genetic analysis to treatment response. ( Amorini, M; Arrigo, T; Briuglia, S; Chirico, V; Ferraù, V; Lacquaniti, A; Loddo, I; Salpietro, C; Salpietro, V, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chirico, V | 1 |
| Ferraù, V | 1 |
| Loddo, I | 1 |
| Briuglia, S | 1 |
| Amorini, M | 1 |
| Salpietro, V | 1 |
| Lacquaniti, A | 1 |
| Salpietro, C | 1 |
| Arrigo, T | 1 |
| Guillín-Amarelle, C | 1 |
| Sánchez-Iglesias, S | 1 |
| Araújo-Vilar, D | 1 |
| Kutbay, NO | 1 |
| Yurekli, BS | 1 |
| Onay, H | 1 |
| Altay, CT | 1 |
| Atik, T | 1 |
| Hekimsoy, Z | 1 |
| Saygili, F | 1 |
| Akinci, B | 1 |
| Valizadeh, N | 1 |
| Tehrani, MR | 1 |
| Amoli, MM | 1 |
| Bandarian, F | 1 |
| Collet-Gaudillat, C | 1 |
| Billon-Bancel, A | 1 |
| Beressi, JP | 1 |
1 review available for metformin and Dunnigan Syndrome
| Article | Year |
|---|---|
[Uncommon lipodystrophic syndromes].
Topics: Acro-Osteolysis; Adipose Tissue; Aging, Premature; Body Composition; Cardiovascular System; Combined | 2015 |
4 other studies available for metformin and Dunnigan Syndrome
| Article | Year |
|---|---|
LMNA gene mutation as a model of cardiometabolic dysfunction: from genetic analysis to treatment response.
Topics: Adolescent; Amenorrhea; Body Fat Distribution; Cardiovascular Diseases; DNA Mutational Analysis; Fem | 2014 |
A case of familial partial lipodystrophy caused by a novel lamin A/C (LMNA) mutation in exon 1 (D47N).
Topics: Adult; Diabetes Mellitus; Exons; Fatty Liver; Female; Heterozygote; Humans; Insulin; Insulin Resista | 2016 |
Severe acanthosis nigricans in a 17 year-old female with partial lipodystrophic syndrome.
Topics: Acanthosis Nigricans; Adolescent; Diet Therapy; Diet, Carbohydrate-Restricted; Diet, Fat-Restricted; | 2008 |
Long-term improvement of metabolic control with pioglitazone in a woman with diabetes mellitus related to Dunnigan syndrome: a case report.
Topics: Adipose Tissue; Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; | 2009 |